MERCK INC

Company Introduction: Merck Inc., Philippines

Merck Inc. in the Philippines is the local subsidiary of Merck KGaA, a leading global science and technology company headquartered in Darmstadt, Germany. The company operates across three main business sectors: Healthcare, Life Science, and Performance Materials.

In the Philippines, Merck Inc. primarily focuses on the sales, marketing, and distribution of its diverse product portfolio. This includes innovative prescription drugs, over-the-counter products, life science tools and materials for research and biotechnology, and high-tech materials for various industries.

Factory or Trader: Trader

Merck Inc. in the Philippines functions predominantly as a trader and distributor. While it manages local market operations, sales, and marketing for Merck KGaA's products, its core activity is not large-scale manufacturing of finished goods within the Philippines. Products are typically imported and then distributed to local healthcare providers, research institutions, and industrial customers.

Merck Inc. (known as MSD outside of the United States and Canada) in the Philippines primarily sells and distributes a range of pharmaceutical products and vaccines across various therapeutic areas.

Key product categories and examples include:

Pharmaceuticals

Oncology

KEYTRUDA (pembrolizumab)

Diabetes

JANUVIA (sitagliptin)

JANUMET (sitagliptin and metformin)

Cardiovascular Disease

COZAAR (losartan)

Infectious Diseases

ISENTRESS (raltegravir) for HIV treatment

CUBICIN (daptomycin) for serious bacterial infections

Vaccines

Human Papillomavirus (HPV) vaccine (e.g., GARDASIL)

Pneumococcal vaccine (e.g., PNEUMOVAX 23)

Measles, Mumps, Rubella (MMR) vaccine (e.g., MMR II)

Varicella (Chickenpox) vaccine (e.g., VARIVAX)

Rotavirus vaccine (e.g., ROTATEQ)